Abstract
The purpose of the present experiment was to determine whether the effects of opioids with varying degrees of efficacy at the mu receptor are differentially altered in morphine-tolerant pigeons. To this end, dose-effect curves were determined for high, intermediate, and low efficacy mu agonists in pigeons responding under a schedule of food presentation prior to, during, and after exposure to a regimen of chronic morphine administration. In pigeons treated with 56 mg/kg/daily morphine, the dose-effect curves for the rate-decreasing effects of the high-efficacy mu agonists morphine and fentanyl were shifted to the right of their prechronic positions (i.e., tolerance). A small degree of tolerance was also conferred to the intermediate-efficacy mu agonists (−)-pentazocine and (−)-metazocine, but not to nalbuphine or butorphanol. In contrast to the effects obtained with these mu agonists, the chronic morphine regimen shifted the dose-effects curves of the mu antagonist naloxone and the low-efficacy mu agonists nalorphine and levallorphan to the left of their prechronic positions (i.e., enhanced sensitivity). These findings demonstrate that morphine tolerance confers cross-tolerance to other high efficacy mu agonists, enhanced sensitivity to mu antagonists and low efficacy mu agonists, and little or no cross-tolerance to intermediate efficacy mu agonists. Disadvantages of using schedule-controlled responding to examine the effects of intermediate efficacy mu agonists are discussed.
Similar content being viewed by others
References
Adams JU, Holtzman SG (1990) Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats. Psychopharmacology 100:451–458
Craft RM, Picker MJ, Dykstra LA (1989) Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation. J Pharmacol Exp Ther 249:386–393
Doty P, Picker MJ, Dykstra LA (1989) Cross-tolerance to opioids in morphine-tolerant squirrel monkeys responding under a schedule of food presentation. Eur J Pharmacol 174:171–180
Dykstra LA (1990) Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. J Pharmacol Exp Ther 254:245–252
Dykstra LA, Picker MJ, Powell KR (1990) Stereospecificity of mixed-action opioid agonists/antagonists in morphine-tolerant squirrel monkeys. Pharmacol Biochem Behav 36:639–644
France CP, Woods JH (1985) Effects of morphine, naltrexone, and dextrorphan in untreated and morphine-treated pigeons. Psychopharmacology 85:377–382
France CP, Woods JH (1989) Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys. J Pharmacol Exp Ther 250:937–943
France CP, Woods JH (1990) Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. J Pharmacol Exp Ther 254:626–632
Gellert VF, Holtzman SG (1979) Discriminative stimulus effects of naltrexone in the morphine-dependent rat. J Pharmacol Exp Ther 211:596–605
Gellert VF, Sparber SB (1977) A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats. J Pharmacol Exp Ther 201:44–54
Gmerek DE, Dykstra LA, Woods JH (1987) Kappa opioids in rhesus monkeys III. Dependence associated with chronic administration. J Pharmacol Exp Ther 242:428–436
Herling S, Solomon RE, Woods JH (1983) Discriminative stimulus effects of dextrorphan in pigeons. J Pharmacol Exp Ther 227:723–731
James IF, Goldstein A (1984) Site-directed alkylation of multiple opioid receptors: I. Binding selectivity. Mol Pharmacol 25:337–342
Katz JL (1986) Tolerance to effects of morphine without cross tolerance to effects of clonidine on schedule-controlled behavior of pigeons. Psychopharmacology 89:323–326
Leander JD (1983) A kappa opioid effect: Increased urination in the rat. J Pharmacol Exp Ther 224:89–94
Magnan J, Paterson SJ, Tavani A, Kosterlitz HW (1982) The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Arch Pharmacol 319:197–205
Mansour A, Akil H, Essman W, Watson SJ (1987) Heterogeneity of kappa opioid receptors across species. Soc Neurosci Abstr 13:638
Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. TINS 7:308–314
Martin WR (1979) History and development of mixed opioid agonists, partial agonists and antagonists. Br J Clin Pharmac 7:272S-279S
Miller L, Shaw JS, Whiting EM (1986) The contribution of intrinsic activity to the action of opioids in vitro. Br J Pharmacol 87:595–601
Negus SS, Picker MJ, Dykstra LA (1989) Kappa antagonist properties of buprenorphine in non-tolerant and morphine-tolerant rats. Psychopharmacology 98:141–143
Negus SS, Picker MJ, Dykstra LA (1991) Interactions between the discriminative stimulus effects of mu and kappa opioids in the squirrel monkey. J Pharmacol Exp Ther 256:149–158
O'Donnell JM (1990) Behavioral effects of beta adrenergic agonists and antidepressants drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol. J Pharmacol Exp Ther 254:147–157
Oliveto AH, Picker MJ, Dykstra LA (1991) Acute and chronic morphine administration: effects of mixed action opioids in rats and squirrel monkeys under a schedule of food presentation. J Pharmacol Exp Ther 257:8–18
Picker MJ, Dykstra LA (1989) Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists. J Pharmacol Exp Ther 249:557–566
Picker MJ, Dykstra LA (1990) Isomeric differences in the discriminative stimulus properties of n-allylnormetazocine (NANM) in the pigeon. FASEB J 4:331
Picker MJ, Negus SS, Dykstra LA (1989) Opioid-like discriminative stimulus properties of benzomorphans in the pigeon: stereospecificity and differential substitution patterns. Life Sci 44:1637–1645
Picker MJ, Negus SS, Craft RM (1990a) Butorphanol: evaluation of efficacy at mu and kappa opioid receptors in non-tolerant and morphine-tolerant rats responding under a fixed-ratio schedule and in rats responding under a drug discrimination procedure. Pharmacol Biochem Behav 36:563–568
Picker MJ, Negus SS, Craft RM, Yarbrough J, Dykstra LA (1990b) Effects of mixed action opioids in morphine-tolerant animals. Pharmacol Biochem Behav 36:438
Picker MJ, Negus SS, Powell KR (1990c) Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant and non-tolerant rats responding under a schedule of food presentation. Psychopharmacology 103:129–135
Pircio AW, Gylys JA, Cavanagh RJ, Buyniski JP, Bierwagen ME (1976) The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic. Arch Int Pharmacodyn 220:231–257
Schmidt WK, Tam SW, Shotzberger GS, Smith DH Jr, Clark R, Vernier VG (1985) Nalbuphine. Drug Alcohol Depend 14:339–362
Schulz R, Wuster M, Rubini P, Herz A (1981) Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development. J Pharmacol Exp Ther 219:547–550
Shannon HE (1982) Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats. J Pharmacol Exp Ther 222:146–151
Shannon HE (1983) Pharmacological evaluation of N-allylnormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat. J Pharmacol Exp Ther 225:144–152
Shannon HE, Holtzman SG (1979) Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology 61:239–244
Shearman GT, Herz A (1982) Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate K-receptor agonists. Psychopharmacology 78:63–66
Solomon RE, Goodrich JE, Katz JL (1988) Opioid receptor subtype-specific cross-tolerance to the effects of morphine on schedule-controlled behavior in mice. Psychopharmacology 96:218–222
Stevens CW, Yaksh TL (1989) Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance under continuous infusion. J Pharmacol Exp Ther 250:1–8
Takada K, Suzuki T, Hagen T, Cook JM, Katz JL (1989) Behavioral effects of benzodiazepine antagonists in chlordiazepoxide tolerant and non-tolerant rats. Life Sci 44:289–299
Tallarida RJ, Murray RB (1987) Manual of pharmacologic calculations with computer programs. Springer, Berlin Heidelberg New York
Villarreal JE, Karbowski MG (1974) The actions of narcotic antagonists in morphine-dependent rhesus monkeys. In: Braude MC, Harris LS, May EL, Smith JP, Villarreal JE (eds) Narcotic antagonists. Raven Press, New York, pp 273–289
Wenger GR (1988) Chronic administration of S-(−)-pentobarbital in pigeons and rats: Tolerance development. Pharmacol Biochem Behav 31:459–465
Wenger GR (1980) Cumulative dose-response curves in behavioral pharmacology. Pharmacol Biochem Behav 13:647–651
White JM, Holtzman SG (1983) Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties. J Pharmacol Exp Ther 224:95–99
Wood PL, Charleson SE, Lane D, Hudgin RL (1981) Multiple opiate receptors: differential binding of μ, κ and delta agonists. Neuropharmacology 20:1215–1220
Woods JH, Winger G (1987) Behavioral characterization of opioid mixed agonist-antagonists. Drug Alcohol Depend 20:303–315
Young AM, Thompson T (1978) Effects of naloxone on schedule-controlled behavior in morphine-maintained pigeons. J Pharmacol Exp Ther 205:236–245
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Picker, M.J., Yarbrough, J. Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor. Psychopharmacology 105, 459–466 (1991). https://doi.org/10.1007/BF02244364
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244364